Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (unaudited) - USD ($)	Total	Adjusted balance	Redeemable Convertible Preferred Stock	Redeemable Convertible Preferred Stock Adjusted balance	Common Stock	Common Stock Adjusted balance	Additional Paid-in Capital	Additional Paid-in Capital Adjusted balance	Accumulated Deficit	Accumulated Deficit Adjusted balance	Accumulated Other Comprehensive (Loss) Income
Beginning Balance at Dec. 31, 2020	$ (104,902,000)	$ (104,902,000)					$ 9,905,000.00	$ 9,905,000	$ (114,807,000)	$ (114,807,000)
Temporary Equity, Beginning Balance, Shares at Dec. 31, 2020			23,785,202	27,381,299
Temporary Equity, Beginning Balance at Dec. 31, 2020			$ 116,886,000	$ 116,886,000
Beginning Balance, Shares at Dec. 31, 2020					1,157,868	1,332,926
Retroactive application of recapitalization (Note 1)					175,058
Retroactive application of recapitalization (Note 1), Shares, Temporary Equity			3,596,097
Stock-based compensation expense	4,913,000						4,913,000
Exercise of stock options	264,000						264,000
Exercise of stock options, Shares					341,180
Issuance of common stock warrants	268,000						268,000
Issuance of convertible preferred stock, net of issuance costs			$ 109,681,000
Issuance of convertible preferred stock, net of issuance costs, Shares			15,027,076
Stock dividend accrued for Series D preferred stock	(6,660,000)						(4,661,000)		(1,999,000)
Stock dividend accrued for Series D preferred stock, Temporary Equity			$ 6,660,000
Stock dividend accrued for Series D preferred stock, Shares, Temporary Equity			909,843
Redemption value of Series D preferred stock	(58,649,000)						(10,689,000)		(47,960,000)
Redemption value of Series D preferred stock, Temporary Equity			$ 58,649,000
Net loss	(61,348,000)								(61,348,000)
Ending Balance at Dec. 31, 2021	$ (226,114,000)								(226,114,000)
Temporary Equity, Ending Balance, Shares at Dec. 31, 2021	43,318,218		43,318,218
Temporary Equity, Ending Balance at Dec. 31, 2021	$ 291,876,000		$ 291,876,000
Ending Balance, Shares at Dec. 31, 2021					1,674,106
Stock-based compensation expense	8,574,000						8,574,000
Exercise of stock options	$ 149,000						149,000
Exercise of stock options, Shares	116,299				116,299
Stock dividend accrued for Series D preferred stock	$ (7,383,000)						(4,865,000)		(2,518,000)
Stock dividend accrued for Series D preferred stock, Temporary Equity			$ 7,383,000
Stock dividend accrued for Series D preferred stock, Shares, Temporary Equity			1,008,596
Redemption value of Series D preferred stock	(3,692,000)								(3,692,000)
Redemption value of Series D preferred stock, Temporary Equity			$ 3,692,000
Redemption value of Series D preferred stock, Shares, Temporary Equity			8,472,752
Exercise of Legacy Akili warrants					8,834
Vesting of common stock warrants	282,000						282,000
Conversion of redeemable preferred stock into common stock, Temporary Equity			$ (302,951,000)
Conversion of redeemable preferred stock into common stock, Shares, Temporary Equity			(52,799,566)
Conversion of redeemable preferred stock into common stock	302,951,000				$ 5,000		302,946,000
Conversion of redeemable preferred stock into common stock, Shares					52,799,566
Issuance of common stock related to Business Combination and PIPE Investment	164,283,000				$ 3,000		164,280,000
Issuance of common stock related to Business Combination and PIPE Investment, Shares					23,367,500
Reverse recapitalization, net of transaction costs (including ($87,512) of deemed dividends related to Earn-Out Shareholders)	(120,386,000)						(120,386,000)
Vesting of RSUs					56,619
Other comprehensive loss	(21,000)										$ (21,000)
Net loss	(7,964,000)								(7,964,000)
Ending Balance at Dec. 31, 2022	$ 110,679,000				$ 8,000		$ 350,980,000		$ (240,288,000)		$ (21,000)
Temporary Equity, Ending Balance, Shares at Dec. 31, 2022	0
Ending Balance, Shares at Dec. 31, 2022					78,022,924